L-arginine transport in the human coronary and peripheral circulation.
BACKGROUND
Nitric oxide synthase (NOS) uses arginine for the production of nitric oxide (NO). High intracellular concentrations of arginine suggest that NOS activity should be independent of plasma arginine supply. However, under certain conditions, increased plasma arginine concentrations appear to be associated with increased NOS activity. The purpose of this study was to explore arginine transport within the human coronary and peripheral circulation


RESULTS
Mass-labeled 15N2-arginine was infused to steady state before cardiac catheterization in 31 patients. After diagnostic angiography, a catheter was placed in the coronary sinus. The transcardiac concentration gradient (aorta-coronary sinus) of 15N2-arginine was used as a measure of arginine transport at baseline and during infusions of acetylcholine and N(G)-monomethyl-L-arginine (L-NMMA). No gradient was detected at rest. During the infusion of acetylcholine, a significant gradient was detected (2.5+/-1.2 micromol/L, P=0.01) corresponding to a fractional extraction of 11.7+/-7.5%. This is consistent with in vitro studies that suggest that stimulation of NOS induces arginine transport. During the infusion of L-NMMA, the concentration of 15N2-arginine increased in the coronary sinus, producing a gradient of -3.9+/-1.3 micromol/L (P=0.0002), corresponding to a fractional production of 20.5+/-5.0%. This is consistent with in vitro studies that suggest that L-NMMA induces the efflux of arginine from the cell to the extracellular space via transporter-mediated transstimulation.


CONCLUSIONS
The use of steady-state 15N2-arginine to examine transorgan L-arginine gradients represents a novel tool for the study of L-arginine transport and the mechanisms of endothelial and NOS dysfunction.
Mount Sinai Hospital and University Health Network, University of Toronto, Ontario, Canada.
S E S
SE
Miner
A
A
Al-Hesayen
S
S
Kelly
T
T
Benson
J J
JJ
Thiessen
V R
VR
Young
J D
JD
Parker
D000109:Acetylcholine / Q000494:pharmacology; D000368:Aged; D001120:Arginine / Q000097:blood / Q000493:pharmacokinetics*; D001692:Biological Transport; D001808:Blood Vessels / Q000378:metabolism; D006328:Cardiac Catheterization; D003331:Coronary Vessels / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000201:enzymology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019001:Nitric Oxide Synthase / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III; D009587:Nitrogen Isotopes / Q000493:pharmacokinetics; D009928:Organ Specificity; D019323:omega-N-Methylarginine / Q000494:pharmacology
D009587:Nitrogen Isotopes; D019323:omega-N-Methylarginine; D001120:Arginine; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D000109:Acetylcholine